Literature DB >> 17109632

Cell transplantation with a catheter-based approach: an efficient method for the treatment of heart failure with multiple lesions.

M Chen1, Z-C Fan, X-J Liu, J-L Deng, Q Yang, D-J Huang.   

Abstract

Cell transplantation is emerging as a potential therapeutic approach for the treatment of heart failure. At present, popular methods of cell delivery may not be efficient in perfusing cells through the whole myocardium. We have developed a novel catheter-based method for global transplantation of cells. Heart failure was induced in rabbit by intravenous administration of doxorubicin. Autologous bone marrow mononuclear cells were transplanted into failing hearts via the root of the aorta. Bilateral sinus aortae and coronary arteries were visualized by angiography during the cell transplantation procedure; there was no intraprocedural death. Four weeks after cell transplantation, there was an improvement in the mean left ventricular ejection fraction from baseline 72.13% to 81.54% (P = 0.034). Transplanted cells were observed throughout the cardiac layers of left and right ventricles. In conclusion, cell transplantation through the root of the aorta is a useful approach to globally supply cells into the heart.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109632      PMCID: PMC6496434          DOI: 10.1111/j.1365-2184.2006.00405.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  10 in total

1.  Stem cell therapy for myocardial repair: is it arrhythmogenic?

Authors:  Raj R Makkar; Michael Lill; Peng-Sheng Chen
Journal:  J Am Coll Cardiol       Date:  2003-12-17       Impact factor: 24.094

2.  Delivery of primary autologous skeletal myoblasts into rabbit heart by coronary infusion: a potential approach to myocardial repair.

Authors:  D A Taylor; S C Silvestry; S P Bishop; B H Annex; R E Lilly; D D Glower; W E Kraus
Journal:  Proc Assoc Am Physicians       Date:  1997-05

3.  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).

Authors:  Birgit Assmus; Volker Schächinger; Claudius Teupe; Martina Britten; Ralf Lehmann; Natascha Döbert; Frank Grünwald; Alexandra Aicher; Carmen Urbich; Hans Martin; Dieter Hoelzer; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

4.  Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.

Authors:  Philippe Menasché; Albert A Hagège; Jean-Thomas Vilquin; Michel Desnos; Eric Abergel; Bruno Pouzet; Alain Bel; Sorin Sarateanu; Marcio Scorsin; Ketty Schwartz; Patrick Bruneval; Marc Benbunan; Jean-Pierre Marolleau; Denis Duboc
Journal:  J Am Coll Cardiol       Date:  2003-04-02       Impact factor: 24.094

5.  Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.

Authors:  Bodo E Strauer; Michael Brehm; Tobias Zeus; Matthias Köstering; Anna Hernandez; Rüdiger V Sorg; Gesine Kögler; Peter Wernet
Journal:  Circulation       Date:  2002-10-08       Impact factor: 29.690

6.  Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect.

Authors:  Helen A Papadaki; Heraklis D Kritikos; Claudia Gemetzi; Helen Koutala; Judith C W Marsh; Dimitrios T Boumpas; George D Eliopoulos
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

7.  Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up.

Authors:  Pieter C Smits; Robert-Jan M van Geuns; Don Poldermans; Manolis Bountioukos; Emile E M Onderwater; Chi Hang Lee; Alex P W M Maat; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2003-12-17       Impact factor: 24.094

8.  Adriamycin cardiomyopathy in the rabbit: an animal model of low output cardiac failure with activation of vasoconstrictor mechanisms.

Authors:  L Arnolda; B McGrath; M Cocks; E Sumithran; C Johnston
Journal:  Cardiovasc Res       Date:  1985-06       Impact factor: 10.787

9.  Chronic cardiotoxicity of anticancer anthracyclines in the rat: role of secondary metabolites and reduced toxicity by a novel anthracycline with impaired metabolite formation and reactivity.

Authors:  Giuseppe Sacco; Rossella Giampietro; Emanuela Salvatorelli; Pierantonio Menna; Nicoletta Bertani; Gallia Graiani; Fabio Animati; Cristina Goso; Carlo A Maggi; Stefano Manzini; Giorgio Minotti
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

10.  Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.

Authors:  Israel M Barbash; Pierre Chouraqui; Jack Baron; Micha S Feinberg; Sharon Etzion; Ariel Tessone; Liron Miller; Esther Guetta; Dov Zipori; Laurence H Kedes; Robert A Kloner; Jonathan Leor
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

  10 in total
  1 in total

1.  Naringin protects myocardial cells from doxorubicin‑induced apoptosis partially by inhibiting the p38MAPK pathway.

Authors:  Chun-Yan Jian; Han-Bin Ouyang; Xian-Hong Xiang; Jia-Li Chen; Yong-Xin Li; Xin Zhou; Jin-Yang Wang; Yang Yang; En-Yi Zhong; Wen-Hua Huang; Hong-Wu Zhang
Journal:  Mol Med Rep       Date:  2017-10-19       Impact factor: 2.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.